Detalles de la búsqueda
1.
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Circulation
; 141(10): 843-862, 2020 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992065
2.
Associations of weight loss with obesity-related comorbidities in a large integrated health system.
Diabetes Obes Metab
; 23(12): 2804-2813, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472680
3.
Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association.
Clin Diabetes
; 38(4): 371-381, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132507
4.
Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.
Cardiovasc Diabetol
; 17(1): 54, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29636104
5.
Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system.
Diabetes Obes Metab
; 19(11): 1555-1561, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407414
6.
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.
Curr Diab Rep
; 16(9): 83, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27457238
7.
The Fate of FDA Postapproval Studies.
N Engl J Med
; 377(24): 2404-5, 2017 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29240323
8.
Effect of a High-Fat Meal on Single-Dose Rencofilstat (CRV431) Oral Bioavailability in Healthy Human Subjects.
Clin Pharmacol Drug Dev
; 12(3): 287-293, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251165
9.
Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH.
Hepatol Commun
; 6(12): 3379-3392, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271849
10.
Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study.
Clinicoecon Outcomes Res
; 12: 423-434, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32848433
11.
The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes.
Endocrinol Diabetes Metab
; 3(2): e00106, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318629
12.
Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting.
Clin Diabetes Endocrinol
; 6: 5, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32158550
13.
Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity.
Obes Sci Pract
; 6(3): 247-254, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32523713
14.
Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System.
Diabetes Care
; 43(8): 1937-1940, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414887
15.
The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
Diabetes Care
; 43(8): 1910-1919, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32527797
16.
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
Endocrinol Diabetes Metab
; 2(3): e00076, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294089
17.
Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population.
Clin Ther
; 41(8): 1522-1536.e1, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31196656
18.
Persistence of newer anti-obesity medications in a real-world setting.
Diabetes Res Clin Pract
; 143: 348-356, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30009937
19.
Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.
Am Health Drug Benefits
; 11(6): 310-318, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30464797
20.
Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes.
J Diabetes
; 10(3): 192-199, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28976724